Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class (Ascending) Administration Route Package Effective Date Package Discontinuation Date Status
00591-2233-30 00591-2233 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral March 7, 2011 May 31, 2014 No Longer Used
00591-2472-18 00591-2472 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug. 15, 2011 In Use
00591-2472-60 00591-2472 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug. 15, 2011 In Use
00591-2473-19 00591-2473 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug. 15, 2011 In Use
00591-2473-30 00591-2473 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Aug. 15, 2011 In Use
54569-3765-01 54569-3765 Tamoxifen Citrate Tamoxifen Citrate 10.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Feb. 20, 2003 In Use
54868-4287-00 54868-4287 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 17, 2005 In Use
54868-4287-01 54868-4287 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 17, 2005 In Use
54868-4287-02 54868-4287 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 17, 2005 In Use
54868-4287-03 54868-4287 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 17, 2005 In Use
54868-4287-04 54868-4287 Tamoxifen Citrate Tamoxifen Citrate 20.0 mg/1 Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Jan. 17, 2005 In Use
60505-3035-03 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3035-05 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3035-06 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3035-07 60505-3035 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3036-01 60505-3036 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3036-03 60505-3036 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
60505-3036-07 60505-3036 Tamoxifen Citrate Tamoxifen Citrate Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Nov. 30, 2012 Dec. 1, 2012 No Longer Used
00143-9750-01 00143-9750 Testosterone Enanthate Testosterone Enanthate 200.0 mg/mL Hormonal Therapy Androgen Intramuscular Sept. 18, 2012 In Use
00574-0821-05 00574-0821 Testosterone Enanthate Testosterone Enanthate Hormonal Therapy Androgen Aug. 2, 2007 Sept. 30, 2011 No Longer Used
58468-0030-02 58468-0030 Thyrotropin Alfa Thyrogen 0.9 mg/mL Hormonal Therapy Thyroid Stimulating Hormone Intramuscular Nov. 30, 1998 In Use
54868-5428-00 54868-5428 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Sept. 13, 2006 June 30, 2013 No Longer Used
54868-5429-00 54868-5429 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent March 20, 2008 June 30, 2013 No Longer Used
54868-5867-00 54868-5867 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent March 20, 2008 June 30, 2013 No Longer Used
55513-0006-01 55513-0006 Darbepoetin alfa Aranesp 200.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use

Found 10,000 results in 2 millisecondsExport these results